Cargando…
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
OBJECTIVE: Tissue inhibitor of metalloproteinase 3 (TIMP3) is an extracellular matrix (ECM) bound protein, which has been shown to be downregulated in human subjects and experimental models with cardiometabolic disorders, including type 2 diabetes mellitus, hypertension and atherosclerosis. The aim...
Autores principales: | Stöhr, Robert, Kappel, Ben Arpad, Carnevale, Daniela, Cavalera, Michele, Mavilio, Maria, Arisi, Ivan, Fardella, Valentina, Cifelli, Giuseppe, Casagrande, Viviana, Rizza, Stefano, Cattaneo, Antonino, Mauriello, Alessandro, Menghini, Rossella, Lembo, Giuseppe, Federici, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588459/ https://www.ncbi.nlm.nih.gov/pubmed/26500845 http://dx.doi.org/10.1016/j.molmet.2015.07.007 |
Ejemplares similares
-
Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma
por: Casagrande, Viviana, et al.
Publicado: (2017) -
TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021) -
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
por: Fiorentino, Loredana, et al.
Publicado: (2013) -
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021) -
TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1
por: Cardellini, Marina, et al.
Publicado: (2009)